ASCO 2009: Oestrogen and progestin therapy increases NSCLC risk

Loading...

Sign in or sign up now!
Alert icon
Upgrade to the latest Flash Player for improved playback performance. Upgrade now or more info.
130 views
Loading...
Alert icon
Sign in or sign up now!
Alert icon

Uploaded by on Nov 13, 2009

ASCO 2009: Rowan T. Chlebowski, MD, PhD - Harbor-UCLA Medical Center - Los Angeles: Menopausal Hormone Therapy with Estrogen and Progestin Linked to Increased Risk of Death from Non-Small Cell Lung Cancer Researchers have shown that use of hormone therapy with estrogen plus progestin increases the risk of dying from non-small cell lung cancer (NSCLC) in women with the disease. Lung cancer is the leading cause of cancer death in U.S. women.

Category:

Science & Technology

Tags:

License:

Standard YouTube License

  • likes, 0 dislikes

Link to this comment:

Share to:
see all

All Comments (0)

Sign In or Sign Up now to post a comment!
Loading...

Alert icon
0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more